Medidata alternatives for teams priced out of enterprise pharma software

Most research isn't a top-20 pharma Phase III trial, so most research doesn't need Medidata pricing or a six-month implementation. WeGuide gives academic, CRO, and mid-market teams a regulatory-grade platform with eCOA, eConsent, wearables, and a branded participant app, with configuration typically taking two to four weeks.

Organise a demo See the full comparison

No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.

Where WeGuide differs

Deploy in weeks, not months
Accessible pricing for mid market research
No code programme builder

Used by leading research and medical institutes.

Why research teams look for a Medidata alternative

The short version

The typical Medidata buyer conversation sounds like this: a mid-market sponsor or CRO sits down with a Medidata sales team, describes their study, and gets a quote with a six-figure minimum and a four-to-six month implementation runway. For large, complex pharma portfolios, those numbers are reasonable. For everyone else, they're a wall.

See the full comparison

Why teams look elsewhere

Academic medical centres, mid market CROs, investigator led studies, patient registries, and digital health programmes all have the same problem in different forms: Medidata's strengths are real, but the price point and implementation complexity assume an enterprise programme team and an enterprise budget. When those aren't available, teams start looking for alternatives that cover most of the same ground with a faster, lighter, and more accessible delivery model.

The Medidata "alternatives" conversation also splits in two. Some teams are looking for a Medidata Rave alternative (they need EDC and eCRF). Others are looking for a Medidata CTMS alternative (they need trial management, site management, and financial tracking). We cover both below.

Key differences between WeGuide and Medidata

For teams that don't need Rave's full eCRF depth but do need fast deployment, patient engagement, and a simpler cost story, here's what changes when you move to WeGuide.

Deploy in weeks, not months

Traditional enterprise platforms often require a six-month lead time due to complex delivery models. WeGuide breaks that cycle: configuration alongside your team typically takes two to four weeks. For mid-market sponsors and academic researchers, this speed is the difference between starting your study this quarter or waiting until next year.

Accessible pricing for mid market research

Enterprise solutions often demand six-figure minimums, pricing out vital academic research and mid-market CRO projects. WeGuide offers a project-based model that scales to your study’s actual complexity. Our core license includes every essential module from eCOA and eConsent to wearables and analytics so you never have to pay for a fragmented menu of expensive, disconnected add-on services.

No code programme builder

Eliminate the need for dedicated clinical data managers or specialized implementation teams. With WeGuide’s intuitive no code builder, research teams can configure and manage their own studies directly. By removing the technical gatekeepers required by legacy systems like Rave, we empower your team to take full control of the workflow while significantly reducing the hidden operational costs of running a trial.

Compare

Full comparison: WeGuide vs Medidata

REDCap

Feature

Request a Demo

Primary use case

Patient engagement platform with eCOA, eConsent, registries, wearables

Enterprise EDC (Rave) and clinical trial management (CTMS) for pharma

Target customer

Mid market sponsors, academic research, CROs, registries

Top 50 pharma, large global CROs, late stage enterprise trials

Typical deployment time

Typically two to four weeks of configuration

3 to 6 months for a full study configuration

Pricing model

Project based, all modules included

Enterprise custom quoted, typically six figure minimums

eCOA and ePRO

Native with a validated instrument library

Patient Cloud module, deep validated library

Whitelabel mobile app

Yes, fully branded under your organisation

MyMedidata, Medidata branded participant experience

Wearable integration

Native Garmin, Apple Health, Health Connect, and Fitbit Air

Supported through Medidata Sensor Cloud and partners

No code programme builder

Yes, research teams configure studies directly

Dedicated clinical data manager and implementation team required

Patient registry

Built in registry capability (GenV: about 124,000 people)

Not a native use case

Employee wellbeing and population health

Built in

Outside the platform's scope

Telehealth

Built in video visit and virtual site features

Requires partner integration

Regulatory certification

TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR

21 CFR Part 11 across the Rave stack, extensive FDA submission history

eCRF depth for complex pharma protocols

Form Builder covers most use cases, deeper capture through Integration Engine

Deepest eCRF library in the industry, decades of regulatory accepted design

Hosting and support model

Managed cloud with named research delivery contact

Enterprise managed with dedicated implementation team

REDCap

Top alternatives to Medidata in 2026

Here's the shortlist of platforms most teams evaluate when they're moving on from Medidata, or when Medidata's pricing rules it out. Each one has a different sweet spot.

Alternative #1

Where WeGuide goes further

For teams that want the participant side of a study in one platform, here's what changes when you move to WeGuide.

Deploy in weeks, not months

Accessible pricing for mid-market research

No-code programme builder

Whitelabel mobile apps under your brand

Native Garmin, Apple Health, Health Connect, and Fitbit Air

Built-in patient registry capability

Use cases beyond pharma trials

Medidata CTMS vs WeGuide

Built for regulated research

Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.

TGA Registered

Registered Class I medical device software with the Therapeutic Goods Administration.

ISO 27001

Certified information security management covering access, audit, and incident response.

Data Hosted in Australia

Participant data is hosted in Australian data centres with sovereign data controls.

GDPR Compliant

GDPR, HIPAA, and 21 CFR Part 11 ready for multi-country and US-based studies.

Biometric Security

Participant access protected by PIN code and biometric authentication on device.

256-bit AES Encryption

All data encrypted at rest and in transit with automated backups and disaster recovery.

Where Medidata excels

Market-leading EDC with Rave. Medidata Rave has been the category-defining EDC for two decades. Its eCRF designer, edit-check engine, query management, and data validation have been refined through tens of thousands of studies. For complex late-stage pharma trials, this is still the benchmark.

Enterprise-grade CTMS, RTSM, eCOA, safety, and CDB. Medidata has built out a comprehensive suite that covers most of the clinical trial technology stack. Acorn for safety, Patient Cloud for eCOA, Rave RTSM for randomisation, and the Medidata Clinical Data Studio for analytics and CDB. For teams that want one vendor across the whole stack, this is a real strength.

Part of Dassault Systèmes. The parent company brings R&D investment, enterprise support, and integration with the Dassault portfolio. That matters for some enterprise sponsors.

FDA 21 CFR Part 11 across the stack. Regulatory-grade compliance at enterprise scale, with a long track record of FDA submissions accepting Medidata-sourced data.

Strong in complex, late-stage, global Phase II to IV pharma trials. This is Medidata's home turf, and it's genuinely hard to match at that scale.

If your study is a top-20 pharma late-stage multi-site trial, Medidata is a defensible choice. We'd rather tell you that honestly than pretend WeGuide replaces it in every scenario.

run WeGuide alongside Medidata

If your enterprise portfolio already runs on Medidata Rave for complex late-stage trials, you don't have to rip that out to use WeGuide for your mid-market or engagement-heavy studies. Our Integration Engine connects to Medidata through its APIs, so you can keep Rave for the protocols it suits and run WeGuide for the ones that need faster deployment, patient engagement, or lower cost. Many of the teams we work with run hybrid architectures.

How the switch works

For teams that are ready to move beyond Medidata for specific studies or run WeGuide alongside it, here's how onboarding typically plays out.

Discovery Call

A 30-minute conversation with one of our research delivery team. We look at your protocol, your current Medidata setup, and what's actually blocking you. No sales pitch.

Study Configuration

Our team works alongside yours to configure the study in WeGuide. If you're keeping Medidata for eCRF data, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.

Participant Onboarding

The whitelabel app goes live. Your research coordinators invite participants, who download the app under your organisation's brand. Consent flows, engagement templates, and eCOA instruments are ready.

Ongoing Support

You get a named research delivery contact, not a ticketing queue. We stay involved for the life of the study.

Case studies: research teams that moved faster than enterprise pharma software allows

BRACE Trial (Murdoch Children's Research Institute)

An international randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity in healthcare workers, run across several countries with thousands of participants. It was a hybrid trial, with in person vaccination and blood collection. WeGuide ran the participant facing digital layer alongside the site visits.

GenV (Generation Victoria)

A population health study following roughly 124,000 Victorians (about 50,000 children from birth and 74,000 parents). Longitudinal registry work at this scale isn't in Medidata's product scope, and the whitelabel family-facing app is the reason retention has held across multiple years.

FSHD Global

A longitudinal patient registry for facioscapulohumeral muscular dystrophy, combining patient reported outcomes with wearable integration. Participants report from home on their own phones, devices sync in the background, and the registry keeps a continuous picture of a rare disease over time instead of a snapshot at each clinic visit.

Helping researchers transform ideas into discoveries.

Hear what our clients have to say!

"GenV trusted WeGuide to run a multi-year population health study with roughly 124,000 Victorians, about 50,000 children and 74,000 parents. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years.""

Susan Clifford

Senior Research Officer

“The main benefit of WeGuide is its convenience. I can’t imagine how we would follow thousands of participants and collect their data without WeGuide!”

Kaya Gardiner

Trial Project Manager

"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."

Emma Weatherley

Managing Director

"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."

Kate Cranwell

Manager

"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."

Paul Eleftheriou

Chief Medical Officer

Questions

Straight answers on how WeGuide compares to Medidata, what migration looks like, and when Medidata is the right call.

Is WeGuide a full replacement for Medidata Rave EDC?

Honestly, for large, complex Phase II to IV pharma trials with hundreds of sites and decades of established eCRF libraries, Rave remains the gold standard and we won't pretend otherwise. WeGuide is the right choice when you're a mid-market sponsor, academic institution, investigator-led study, or CRO that doesn't need Rave's full eCRF depth and doesn't want its pricing and implementation timelines. For teams that need both, we often recommend running WeGuide alongside Rave through our Integration Engine rather than replacing it.

Does WeGuide replace Medidata CTMS?

For mid market and academic studies, yes. WeGuide handles participant management, study configuration, analytics, and operational oversight for the kinds of studies that don't need enterprise multi-programme CTMS features. For large pharma portfolios running hundreds of sites across multiple programmes, Medidata CTMS or Veeva Vault CTMS are better suited to that scale.

How does Medidata pricing compare to WeGuide?

Medidata is enterprise custom quoted, typically with six-figure minimums for a single study and longer for multi programme portfolios. Pricing is also often split across Rave, Patient Cloud, CTMS, Sensor Cloud, and other modules, so the total stack cost can climb quickly. WeGuide is project based and scales to your study's complexity, with every module included in the core licence. For mid market sponsors and academic research, WeGuide is typically significantly less expensive, and the implementation cost is lower because you don't need a dedicated programme team.

Can we migrate data from Medidata Rave to WeGuide?

Yes, through our Integration Engine and data import workflows. Rave integration is supported via the Medidata APIs. Most teams don't do a hard cutover. They run the two platforms side by side until they're confident, then gradually consolidate for new studies while keeping existing Rave studies in place.

Does WeGuide have an eCOA module like Medidata Patient Cloud?

Yes. WeGuide's eCOA is integrated into the Form Builder with a library of validated instruments, and it runs inside the same whitelabel app participants use for the rest of the study. The difference is that Medidata Patient Cloud is a separate module with a separate Medidata-branded participant interface, while WeGuide's eCOA is part of a single integrated participant experience.

How quickly can we deploy?

Configuration alongside your team typically takes two to four weeks, and complex multi-site studies with rigorous compliance requirements are scoped on the discovery call. The reason we can move this fast is that our no code programme builder lets research teams configure studies directly without waiting for an enterprise implementation team.

More comparisons